- Home
- DNN vs HRMY Comparison
DNN vs HRMY Comparison
Compare DNN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- HRMY
- Stock Information
- Founded
- DNN 1936
- HRMY 2017
- Country
- DNN Canada
- HRMY United States
- Employees
- DNN N/A
- HRMY N/A
- Industry
- DNN Other Metals and Minerals
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- HRMY Health Care
- Exchange
- DNN Nasdaq
- HRMY Nasdaq
- Market Cap
- DNN 1.8B
- HRMY 2.0B
- IPO Year
- DNN 1997
- HRMY 2020
- Fundamental
- Price
- DNN $1.85
- HRMY $38.98
- Analyst Decision
- DNN Strong Buy
- HRMY Strong Buy
- Analyst Count
- DNN 2
- HRMY 8
- Target Price
- DNN $3.00
- HRMY $55.00
- AVG Volume (30 Days)
- DNN 35.6M
- HRMY 552.4K
- Earning Date
- DNN 02-27-2025
- HRMY 02-20-2025
- Dividend Yield
- DNN N/A
- HRMY N/A
- EPS Growth
- DNN N/A
- HRMY N/A
- EPS
- DNN N/A
- HRMY 2.11
- Revenue
- DNN $2,920,167.00
- HRMY $681,879,000.00
- Revenue This Year
- DNN $226.79
- HRMY $25.07
- Revenue Next Year
- DNN $133.88
- HRMY $19.39
- P/E Ratio
- DNN N/A
- HRMY $18.46
- Revenue Growth
- DNN N/A
- HRMY 25.83
- 52 Week Low
- DNN $1.40
- HRMY $28.14
- 52 Week High
- DNN $2.47
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- DNN 45.98
- HRMY 61.34
- Support Level
- DNN $1.70
- HRMY $37.69
- Resistance Level
- DNN $1.93
- HRMY $39.92
- Average True Range (ATR)
- DNN 0.11
- HRMY 1.46
- MACD
- DNN -0.01
- HRMY -0.01
- Stochastic Oscillator
- DNN 34.09
- HRMY 62.57
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.